FIFTH AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENTShareholder Agreement • January 10th, 2020 • Burning Rock Biotech LTD • Services-medical laboratories • Hong Kong
WHEREAS, the Company, OrbiMed, Casdin, the Key Holders, the WFOE, the HK Company, the Domestic Companies and the other parties thereto are each parties to the Series C+ Preferred Share Purchase Agreement dated as of December 30, 2019 (the “Purchase Agreement”);
SERIES C+ PREFERRED SHARE PURCHASE AGREEMENTPreferred Share Purchase Agreement • January 10th, 2020 • Burning Rock Biotech LTD • Services-medical laboratories • Hong Kong
Each of the parties to this Agreement is referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used herein shall have the meaning set forth in Schedule III attached hereto.
